Vital Healthcare (VHP) announced 1) a 1H23 asset devaluation, 2) the pause of one of its low yielding development projects, 3) its first life sciences development, 4) NZ$200m of potential asset sales, and 5) the extension of its banking facilities
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.